We're excited to officially be part of the Exact family and work together to make #EarlierDetection of cancer a part of routine medical care. Follow @ExactSciences for future updates.
We are excited to announce that we've closed our acquisition of @ThriveDetect, creating a leader in blood-based multi-cancer screening. Learn more here: https://t.co/oRjgFMLdqB
This year, Thrive is contributing to @familyreach's "Hope for the Holidays," a program that provides cancer families with financial resources, because we believe everyone should have a holiday that is merry and bright. Consider joining us by donating here: https://t.co/MdtTZVACUu
The earlier cancer is detected, the more effectively it can be treated, which is why it's important to maintain regular screenings. #BackOnTheBooks#CancerScreenWeek
It's estimated over 275,000 women in the U.S. will receive a #breastcancer diagnosis in 2020. As #SABCS20 is in full swing, Thrive CMO @SamAsgarian_MD writes about the importance of earlier cancer detection and maintaining routine screenings. #CancerScreenWeek#backonthebooks
We are excited to be featured in @DavidShulkin's 2020 inaugural list of the most innovative healthcare companies! It's an honor to be included for our commitment to making earlier cancer detection a part of routine medical care. https://t.co/B260R7SQvv
This lung cancer awareness month, our co-founder and head of research & innovation @IsaacKinde emphasizes the importance of screening & the significant impact our blood test had in detecting lung cancer in our DETECT-A study. The future of #earlierdetection is within reach. #LCAM
“I think it is feasible within the next five years 75% of the cancers in the United States be screen-detected, in theory.”
— Bert Vogelstein, M.D.
@HHMINEWS
#STATSummit#Cancer
"Less than 20% of cancers in the US are detected by screening. They're detected by symptoms when it's too late."
—Bert Vogelstein, M.D.
Director, Center for Pharmaceutical Policy and Prescribing; Investigator, Howard Hughes Medical Institute @HHMINEWS
#STATSummit
"Less that 20% of cancers in the US are detected by screening. They're detected by symptoms, when it's too late."
Bert Vogelstein, explaining the need for cancer blood tests. #STATNews
“Years from now, deaths from pancreatic cancer will be less common and that’s going to be in large part due to earlier detection.” Thank you, Dr. Vogelstein. We are dedicated to making this happen. #itsabouttime@lustgartenfdn@hopkinskimmel
Thank you, Rosemary, for participating in the DETECT-A study and sharing your life changing story with @cure_magazine. You inspire us every day to make #earlierdetection of cancer a reality for more patients. Read the story below. https://t.co/yczaS2DWHL
Today, we're pleased to announce @ExactSciences has agreed to acquire Thrive. Together we can accelerate our mission of detecting more cancers at earlier stages when it can be more effectively treated, and in many cases, cured. https://t.co/yaolMihfy1
Our CMO @SamAsgarian_MD will be talking about the #earlydetection of cancer for the Precision Medicine Leaders Summit's virtual series on precision oncology. Learn more: https://t.co/G8BVcnotdF
Join @MITubiomeclub and their panelists from @pfizer, @Cyclerion, and @ThriveDetect who will share about their career paths, the transition from academia to industry, and experiences being women in #biotech. https://t.co/nLQrZg0zlh
“Cancer does not take a pause." Another piece underscoring the tragic impact delayed screenings due to #COVID19 have had on cancer diagnosis. #BackOnTheBooks https://t.co/wtyKTbDxY1
Thrive has joined @blood_pac ! Thrive is excited to support the Blood Profiling Atlas in Cancer and to ensure the accuracy and clinical utility of blood tests designed to detect cancer earlier, when it is most likely to be cured. @ThriveDetect#liquidbiopsy#cancerdetection
We continue to be inspired by our co-founder, Dr. Bert Vogelstein, who is lending his expertise to fight COVID in tandem with his efforts to advance earlier detection of cancer.
Bert Vogelstein's work has shaped our understanding of the molecular basis of cancer. Now his team at Ludwig Johns Hopkins is racing to test a treatment to prevent #COVID19 deaths, even as it advances a powerful new technology for early cancer detection. https://t.co/dSD6hxOFNP